Puopolo M - Search Results

1

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H. Lu L, et al. Among authors: puopolo m. Gynecol Oncol. 2006 Dec;103(3):990-5. doi: 10.1016/j.ygyno.2006.06.006. Epub 2006 Jul 21. Gynecol Oncol. 2006. PMID: 16859738

2

The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H. Lu L, et al. Among authors: puopolo m. Clin Cancer Res. 2006 Feb 15;12(4):1208-14. doi: 10.1158/1078-0432.CCR-05-1801. Clin Cancer Res. 2006. PMID: 16489075

3

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.

Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H. Wiley A, et al. Among authors: puopolo m. Cancer. 2006 Jul 15;107(2):299-308. doi: 10.1002/cncr.21992. Cancer. 2006. PMID: 16773633 Free article.

4

Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Yu H. Lu L, et al. Among authors: puopolo m. Oncol Res. 2007;16(8):395-403. doi: 10.3727/000000006783980892. Oncol Res. 2007. PMID: 17913048

5

ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy.

Smith S, Su D, Rigault de la Longrais IA, Schwartz P, Puopolo M, Rutherford TJ, Mor G, Yu H, Katsaros D. Smith S, et al. Among authors: puopolo m. J Clin Oncol. 2007 Nov 20;25(33):5172-9. doi: 10.1200/JCO.2007.11.8547. J Clin Oncol. 2007. PMID: 18024864

6

Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.

Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H. Lu L, et al. Among authors: puopolo m. Cancer Invest. 2008 Mar;26(2):185-92. doi: 10.1080/07357900701638343. Cancer Invest. 2008. PMID: 18259951

7

IGF-II promoter methylation and ovarian cancer prognosis.

Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H. Beeghly AC, et al. Among authors: puopolo m. J Cancer Res Clin Oncol. 2007 Oct;133(10):713-23. doi: 10.1007/s00432-007-0211-3. Epub 2007 Jun 14. J Cancer Res Clin Oncol. 2007. PMID: 17569086

8

Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.

Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C, Rigault de la Longrais IA, Puopolo M, Massobrio M, Diamandis EP. Yousef GM, et al. Among authors: puopolo m. J Clin Oncol. 2003 Aug 15;21(16):3119-26. doi: 10.1200/JCO.2003.09.111. J Clin Oncol. 2003. PMID: 12915603

9

[Expression and prognostic significance in epithelial ovarian cancer].

Katsaros D, Yu H, Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M. Katsaros D, et al. Among authors: puopolo m. Minerva Ginecol. 2002 Feb;54(1):15-24. Minerva Ginecol. 2002. PMID: 11828267 Italian.

10

[Growth factors in epithelial ovarian cancer].

Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M, Katsaros D. Piccinno R, et al. Among authors: puopolo m. Minerva Ginecol. 2002 Feb;54(1):33-52. Minerva Ginecol. 2002. PMID: 11828269 Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page